Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial.

Saved in:

Bibliographic Details
Title:	Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial.
Authors:	Yeh, E. Ann, Grover, Stephanie, Powell, Victoria, Alper, Gulay, Banwell, Brenda, Edwards, Kim, Gorman, Mark, Graves, Jennifer, Lotze, Timothy, Mah, Jean, Mednick, Lauren, Ness, Jayne, Obadia, Maya, Slater, Ruth, Waldman, Amy, Waubant, Emmanuelle, Schwartz, Carolyn, Grover, Stephanie A (AUTHOR), Powell, Victoria E (AUTHOR), Banwell, Brenda L (AUTHOR)
Source:	Quality of Life Research. Sep2017, Vol. 26 Issue 9, p2333-2349. 17p. 2 Diagrams, 7 Charts, 1 Graph.
Subjects:	Multiple sclerosis treatment, Quality of life, Patient monitoring, Clinical trials, Patient compliance, Diseases in youths, Mental health, Comparative studies, Drugs, Health behavior, Research methodology, Medical cooperation, Multiple sclerosis, Research, Research funding, Evaluation research, Randomized controlled trials
Abstract:	Purpose: To report the results of a randomized controlled trial using an electronic monitoring device (EM) plus a motivational interviewing (MI) intervention to enhance adherence to disease-modifying therapies (DMT) in pediatric MS.Methods: Fifty-two youth with MS (16.03 ± 2.2 years) were randomized to receive either MI (n = 25) (target intervention) or a MS medication video (n = 27) (attention control). Primary endpoint was change in adherence. Secondary outcomes included changes in quality of life, well-being and self-efficacy. Random effects modeling and Cohen's effect size computation evaluated intervention impact.Results: Longitudinal random effect models revealed that the MI group decreased their EM adherence (GroupxTime interaction = -0.19), while increasing frequency of parental DMT reminder (26.01)/administration (11.69). We found decreased EM use in the MI group at 6 months (Cohen's d = -0.61), but increased pharmacy refill adherence (d = 0.23). Parental reminders about medication increased in MI subjects vs controls (d = 0.59 at 3 months; d = 0.70 at 6 months). We found increases in self-reported adherence (d = 0.21) at 3 but not 6 months, fewer barriers to adherence at three (d = -0.58) and six months (d = -0.31), better physical (d = 0.23 at 3 months; d = 0.45 at 6 months), emotional (d = 0.25 at 3 months) and self-efficacy function (d = 0.55 at 3 months; 0.48 at 6 months), but worse well-being, including self-acceptance (d = -0.53 at 6 months) and environmental mastery (d = -0.42 at 3 and 6 months) in intervention as compared to control patients.Conclusions: Participants receiving MI + EM experienced worsening on objective measures of adherence and increased parental involvement, but improved on some self- and parent-reported measures. MI participants reported improvements in quality of life and self-efficacy, but worsened well-being. [ABSTRACT FROM AUTHOR]
	Copyright of Quality of Life Research is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	Psychology and Behavioral Sciences Collection

Be the first to leave a comment!